Date: Friday, December 6, 2013
Venue: Hilton New Orleans Riverside
This activity is intended for physicians, oncology nurses, nurse practitioners, physician assistants, pharmacists and other health care professionals interested in the treatment and management of patients with Myelodysplastic Syndromes.
Supported by educational grants from: Amgen, Baxter, Celgene, Novartis and Onconova.
Recent developments in clinical, immunophenotypic, and molecular risk analyses have generated major advances for aiding management of patients with myelodysplastic syndromes (MDS). These methods and current therapies, with novel agents and their combinations, will be discussed. Also discussed will be the biologic implications of marrow cell molecular mutations and microenvironmental abnormalities for improving the understanding of pathogenetic lesions underlying this disease.
Criteria for Success
Pierre Fenaux, MD
Professor of Hematology
Hôpital St Louis
Paris 7 University
Peter Greenberg, MD
Professor of Medicine
Stanford University Cancer Center
David Scadden, MD
Gerald and Darlene Jordan Professor of Medicine
Arjan van de Loosdrecht, MD, PhD
Professor of Hematology
VU University Medical Center
Amsterdam, The Netherlands
CME/CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of AKH Inc. and MDS Foundation. AKH Inc. is accredited by the ACCME to provide continuing medical education for physicians. AKH Inc. designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
AKH Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. AKH Inc. approves this knowledge- based activity for 3.5 contact hour(s) (0.35 CEUs). UAN 0077-9999-13-021-L04-P.
AKH Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.
AKH Inc. designates this educational activity for 3.5 contact hours. Accreditation applies solely to educational activities and does not imply approval or endorsement of any commercial product by the ANCC-COA.